Does NSE’s price capping on SME IPOs mean no multibagger returns on Day 1?
As SME IPOs become a more mainstream asset class for investors, regulators are looking to formalize the market through multiple checks and balances. In one such move, the leading exchange NSE capped the listing price of SME issues at 90%, regardless of the grey market trends. Nephro Care, which had a pre-listing grey market premium … Read more
